If you live in San Antonio long enough you know by now which foods to eat in moderation during Fiesta, or avoid. In this edition of “Health and Medicine,” John Garcia has more on how to avoid packing on those unwanted pounds. Watch the full story at Time Warner Cable News

Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from several Phase 2 and Phase 3 studies evaluating its two investigational, pangenotypic, fixed-dose combination therapies for the treatment of chronic hepatitis C virus (HCV) infection, as well as new data highlighting the potential use of Harvoni® (ledipasvir/sofosbuvir) in adolescents aged 12 to 17. Data were presented […]

Scientists have uncovered a way to improve liver metabolism for those with non-alcoholic fatty liver disease by using an acute dose of an existing diabetes treatment. Read the full story at Science Daily

Fred Poordad, M.D., of the Health Science Center, presents new findings on cirrhosis at the International Liver Congress in Barcelona.

An investigational drug combination offers renewed hope of a cure for chronic hepatitis C (HCV) patients who have tried and failed therapy with the new direct-acting antiviral agents, a researcher said here. Read the full story at MedPage Today